Last Updated: 05/24/24
Diagnostics Evaluation Branch (DEB)
The Diagnostics Evaluation Branch (DEB) facilitates the development of markers and validation of innovative in vitro diagnostics to improve clinical outcomes for cancer patients.
- Stimulating and supporting research to use in vitro diagnostics as prognostic markers to improve tumor classification and predictive markers to improve response to therapy.
- Collaborating with other researchers and Government agencies to analytically and clinically validate in vitro diagnostics and their clinical utility.
DEB Staff
| Name | Position | Primary Email | Phone |
|---|---|---|---|
| Magdalena Thurin, Ph.D. | Acting Branch Chief | thurinm@mail.nih.gov | (240) 276-5973 |
| Nina Lukinova, Ph.D. | Program Director | nina.lukinova@nih.gov | (240) 276-5309 |
| Sumana Dey, Ph.D. | Program Director | Sumana.Dey@nih.gov | (240) 276-5748 |
| Sanita Bharti, Ph.D. | Program Director | Sanita.bharti@nih.gov |